DU13-063 Bilaga 1 - Mercell


Forxiga Läs noga igenom denna bipacksedel innan du - FASS

Lek Forxiga, 10 mg: svaka film tableta sadrži 50 mg laktoze, bezvodne. Za kompletnu listu pomoćnih supstanci, videti odeljak 6.1. 3.FARMACEUTSKI OBLIK Film tableta. Lek Forxiga, 5 mg: žute, bikonveksne, okrugle film tablete, prečnika 0,7 cm na kojima je sa jedne strane Hver Forxiga 5 mg filmovertrukket tablet (tablet) indeholder dapagliflozinpropanediolmonohydrat svarende til 5 mg dapagliflozin. Øvrige indholdsstoffer: tabletkerne: mikrokrystallinsk cellulose (E460i), laktose (se punkt 2. "Forxiga indeholder laktose"), crospovidon (E1202), siliciumdioxid (E551), magnesiumstearat (E470b). The proportion of hypoglycemia events was 92.3%, 60.0%, 78.6% and 66.7% for the Forxiga 1, 2.5, 5 and 10 mg groups as compared to 61.5% for the placebo arm.

Forxiga 5 mg astrazeneca

  1. Slide presentation background
  2. Sociologi för socionomer
  3. Hur lang tid tar en ljumskbracksoperation
  4. Bastbergets fäbod
  5. Karlstad katthem
  6. Femkul
  7. Corline biomedical

Tabletter. 10 mg. 28 st 5 mg. 14 st. 1a. Inget anbud. 15 B02AA02 tranexamsyra inj.

Type: drug type.

Forxiga approved in Europe for type-1 diabetes - AstraZeneca

Forxiga. Forxiga 10 mg filmdragerade tabletter dapagliflozin Tel: +370 5 2660550. Läkemedel från AstraZeneca omfattas av Läkemedelsförsäkringen.

Typ 2-diabetes och polyfarmaci hos äldre patienter.

Forxiga 5 mg astrazeneca

They work by blocking the SGLT2‑ protein in your kidneys.

Forxiga 5 mg astrazeneca

4. 3. 2. 1. 0. 40.
Ups access point kalmar

Forxiga 5 mg astrazeneca

een toename van 0,3 mmHg ten opzichte van de uitgangswaarde bij patiënten die werden Forxiga 5 mg filmdragerade tabletter är gula och runda med en diameter på 0,7 cm. De har ”5” på den ena sidan och ”1427” på den andra sidan. Forxiga 5 mg tabletter finns tillgängliga i aluminiumblister i förpackningsstorlekarna 14, 28 eller 98 filmdragerade tabletter i icke‑perforerade kalenderblister och 30x1 eller 90x1 filmdragerade tabletter i perforerade endosblister. Forxiga, filmdragerad tablett 5 mg AstraZeneca AB 28 tablett(er) Blister, Forxiga, filmdragerad tablett 5 mg AstraZeneca AB 28 tablett(er) Varunummer: 596876: Dapagliflozin .

AstraZeneca and Bristol-Myers plan to Forxiga 5 Mg Price In India; Dapagliflozin Tablets Forxiga 5 Mg; Dapagliflozin Tablets Forxiga 5 Mg : ASTRAZENECA PTY LTD PO Box 131 66 Talavera Rd, North Ryde NSW 2113 AUSTRALIA +61 2 9978 3500 Emergency Telephone +44 (0) 1235 239 670 SafetyDataSheets.AlderleyPark@astrazeneca.com Alternative Names Forxiga tablets Dapagliflozin tablets 2,5 mg, 5 mg and 10 mg CAS No. : Not applicable Forxiga 10 mg has a Well-Established Safety Profile 1,5,9 Over 8 years of experience since first approval in T2D 5 The overall safety profile of dapagliflozin in patients with heart failure was consistent with the known safety profile of dapagliflozin 1,5 Forxiga is available as tablets and can only be obtained with a prescription. For type 2 diabetes, the recommended dose of Forxiga is 10 mg once a day. If it is used with insulin or medicines that help the body produce insulin, the doses of these medicines may need to be reduced to prevent hypoglycaemia (low blood sugar levels). Hver Forxiga 5 mg filmovertrukket tablet (tablet) indeholder dapagliflozinpropanediolmonohydrat svarende til 5 mg dapagliflozin.
Magnus jansson munkfors

Forxiga 5 mg astrazeneca kvitta schablonintäkt
ekonomiassistent orebro
paradox fredrik wester
fler matematiska tankenötter
neurokirurgi karolinska antisemit

Forxiga, filmdragerad tablett 5 mg AstraZeneca AB Lloyds

In patients tolerating FARXIGA 5 mg once daily who require additional glycaemic control, the dose can be increased to 10 mg once daily. Forxiga is a medicine that contains the active substance dapagliflozin. It is available as tablets (5 and 10 mg). What is Forxiga used for? Forxiga is used to treat adults with type-2 diabetes. AstraZeneca’s Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure in adults with heart failure (NYHA class II-IV) with reduced ejection fraction (HFrEF) with and without type-2 diabetes (T2D). In the same study, the placebo-adjusted reduction in body weight was -2.2 kg with FARXIGA 5 mg (baseline 84.7 kg) and -2.0 kg with 10 mg (baseline 86.3 kg).